脂毒性
粒体自噬
蛋白质组学
下调和上调
心肌病
细胞外基质
代谢组学
细胞生物学
线粒体
酒精性心肌病
生物
基因表达谱
转录组
脂肪酸
脂质代谢
化学
脂类学
脂肪酸代谢
医学
糖尿病性心肌病
调节器
表型
生物化学
β氧化
污渍
线粒体基质
微阵列分析技术
生物信息学
基质金属蛋白酶
内科学
代谢途径
细胞外
定量蛋白质组学
内分泌学
系统生物学
代谢组
糖尿病
缺血性心肌病
作者
Qiuhan Lu,Shulin Tang,Sijia Fang,Yan Wu,L Chen,Mintong Liang,Jiaqi Chen,Pengju Wen,Leigang Jin,Jianshe Yu,Feng Jiao,Yan Wu,Guozhi Jiang
标识
DOI:10.1186/s13073-026-01668-0
摘要
BACKGROUND: Diabetic cardiomyopathy (DbCM) is a major complication of type 2 diabetes whose molecular basis in human hearts remains poorly understood. This study aimed to define the multi-omics landscape of DbCM in the human myocardium. METHODS: We performed integrated transcriptomic, 4D-DIA proteomic, and full-spectrum widely targeted metabolomic analysis on left ventricular tissues from matched Chinese cohorts: DbCM (n = 11), non-diabetic cardiomyopathy (n = 11), and healthy donors (n = 4). Key findings were validated by histological assessment and western blotting of candidate proteins. External validation was conducted using public datasets, and phenotypic support was derived from mouse models. RESULTS: Multi-omics profiling revealed distinct, coordinated dysregulation in DbCM. Proteomics and transcriptomics profiling revealed a rewired fatty acid oxidation-mitophagy axis characterized by elevated acyl-CoA synthetase long-chain family member 1 (ACSL1) and suppressed fatty acid synthase (FASN), impaired mitochondrial quality control marked by a significant reduction in the mitophagy regulator BNIP3L, which showed a strong inverse correlation with ACSL1, and disrupted extracellular matrix homeostasis, with specific downregulation of key structural components (COL5A1, COL5A2, and fibrillin-1). Metabolomics confirmed enhanced but incomplete fatty acid oxidation, evidenced by triglyceride depletion and accumulation of acylcarnitines and lipotoxic lipids. Integrated multi-omics identified impaired BNIP3L-associated mitophagy as a potential molecular node associated with lipid metabolic dysregulation with mitochondrial dysfunction. CONCLUSIONS: This human multi-omics study defines DbCM by the concurrent dysregulation of cardiac fuel metabolism, mitochondrial quality control, and matrix remodeling, offering novel mechanistic insights and highlighting ACSL1 and BNIP3L as potential therapeutic targets for diabetes-associated cardiac dysfunction.
科研通智能强力驱动
Strongly Powered by AbleSci AI